Trial intelligence / Profile preview

Dydrogesterone for Sexual Function in Endometriosis

NCT04287205Completed

Sponsor
Kanuni Sultan Süleyman Training and Research Hospital
Start
Apr 2019
Primary completion
Feb 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label, single-arm trial of dydrogesterone in endometriosis, sponsored by Kanuni Sultan Süleyman Training and Research Hospital. Primary endpoint: Female Sexual Function Index at 6 months. Started Apr 2019; status: completed.

02

Drugs

dydrogesterone
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT04287205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04287205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call